NCT06758661View on ClinicalTrials.gov

Clinical Study to Evaluate Drug-drug Interaction and Safety After Co-administration of D352 and D794 in Healthy Adult Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 27, 2024

Primary Completion Date

January 24, 2025

Study Completion Date

February 3, 2025

Conditions
Dyslipidemia
Interventions
DRUG

D352

1 tablet

DRUG

D794

4 capsule

Trial Locations (1)

08779

H Plus Yangji Hospital, Gwanak-gu

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY